Avalo Therapeutics (NASDAQ:AVTX) Stock, Earnings Estimates, EPS, And Revenue

Avalo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS
$-2.830
Quarterly Revenue
$249K
Annual Revenue
(as of Sep 30)
$820K

Analyze the earnings history of Avalo Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Avalo Therapeutics (AVTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-07$-2.83$-1.45-95.2 %
Jun 20242024-08-12$-14.07$-6.70-110.0 %
Mar 20242024-05-13$-6.11$-1.18-417.8 %
Dec 20232024-03-29$-10.12$-4.80-110.8 %

Avalo Therapeutics (AVTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Dec 20232024-03-29$571.00K$300.00K90.3 %
Sep 20232023-11-09$236.00K$1.00M-76.4 %
Jun 20232023-08-03$643.00K$500.00K28.6 %
Mar 20232023-05-04$475.00K$1.00M-52.5 %

FAQ

Q

When is Avalo Therapeutics (NASDAQ:AVTX) reporting earnings?

A

Avalo Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Avalo Therapeutics (NASDAQ:AVTX)?

A

Avalo Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-2.83, which missed the estimate of $-1.45.

Q

What were Avalo Therapeutics’s (NASDAQ:AVTX) revenues?

A

Avalo Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch